Takeda Wants to Be Global GI Leader in 2025, Not in Acquisition Frenzy Mode: CEO

Takeda CEO Christophe Weber at Interview with Jiho Takeda Pharmaceutical aspires to be the global GI leader in 2025, while joining the top 10 league in oncology, and solidifying its presence in CNS and emerging markets, CEO Christophe Weber told...read more